Mitochondrial bioenergetics are critical for cellular homeostasis and stress responses. The reactive oxygen speciesgenerating enzyme, NADPH oxidase 4 (Nox4), regulates a number of physiological and pathological processes, including cellular differentiation, host defense, and tissue fibrosis. In this study we explored the role of constitutive Nox4 activity in regulating mitochondrial function. An increase in mitochondrial oxygen consumption and reserve capacity was observed in murine and human lung fibroblasts with genetic deficiency (or silencing) of Nox4. Inhibition of Nox4 expression/activity by genetic or pharmacological approaches resulted in stimulation of mitochondrial biogenesis, as evidenced by elevated mitochondrial-to-nuclear DNA ratio and increased expression of the mitochondrial markers transcription factor A (TFAM), citrate synthase, voltage-dependent anion channel (VDAC), and cytochrome c oxidase subunit 4 (COX IV). Induction of mitochondrial biogenesis was dependent on TFAM up-regulation but was independent of the activation of the peroxisome proliferator-activated receptor ␥ coactivator 1-␣ (PGC-1␣). The enhancement of mitochondrial bioenergetics as well as the increase in mitochondrial proteins in Nox4-deficient lung fibroblasts is inhibited by silencing of nuclear factor erythroid-derived 2-like 2 (Nrf2), supporting a key role for Nrf2 in control of mitochondrial biogenesis. Together, these results indicate a critical role for both Nox4 and Nrf2 in counter-regulation of mitochondrial biogenesis and metabolism.
Mitochondrial bioenergetics are critical for cellular homeostasis and stress responses. The reactive oxygen speciesgenerating enzyme, NADPH oxidase 4 (Nox4), regulates a number of physiological and pathological processes, including cellular differentiation, host defense, and tissue fibrosis. In this study we explored the role of constitutive Nox4 activity in regulating mitochondrial function. An increase in mitochondrial oxygen consumption and reserve capacity was observed in murine and human lung fibroblasts with genetic deficiency (or silencing) of Nox4. Inhibition of Nox4 expression/activity by genetic or pharmacological approaches resulted in stimulation of mitochondrial biogenesis, as evidenced by elevated mitochondrial-to-nuclear DNA ratio and increased expression of the mitochondrial markers transcription factor A (TFAM), citrate synthase, voltage-dependent anion channel (VDAC), and cytochrome c oxidase subunit 4 (COX IV). Induction of mitochondrial biogenesis was dependent on TFAM up-regulation but was independent of the activation of the peroxisome proliferator-activated receptor ␥ coactivator 1-␣ (PGC-1␣). The enhancement of mitochondrial bioenergetics as well as the increase in mitochondrial proteins in Nox4-deficient lung fibroblasts is inhibited by silencing of nuclear factor erythroid-derived 2-like 2 (Nrf2), supporting a key role for Nrf2 in control of mitochondrial biogenesis. Together, these results indicate a critical role for both Nox4 and Nrf2 in counter-regulation of mitochondrial biogenesis and metabolism.
Regulation of mitochondrial mass is a tightly controlled process. It is key to pressure-overload adaptation in the heart (1) and to endurance training in the skeletal muscle (2) (3) (4) .
Stress-induced increase in mitochondrial mass results from the stimulation of mitochondrial biogenesis. The mitochondrial transcription factor A (TFAM) 2 (5) ensures mitochondrial DNA replication during mitochondrial biogenesis (6 -8) . The TFAM promoter contains binding sites for transcription factors that are responsive to cellular energy (9) , redox status (10) , and hormonal status (11) . Stress-induced mitochondrial biogenesis is mostly driven by the peroxisome proliferator-activated receptor-␥ coactivator 1-␣ (PGC-1␣) (12) (13) (14) (15) (16) , which is upstream of TFAM (5) . PGC-1␣ is a central integrator of multiple signaling pathways that regulates transcriptional cascades involved in mitochondrial biogenesis (13, (17) (18) (19) . In particular, PGC-1␣ co-activates nuclear respiratory factor-1 (NRF-1) activity at the TFAM promoter. Nuclear factor erythroid-derived 2-like 2 (Nrf2) has also been reported to control oxidative stress or exercise-induced mitochondrial biogenesis via promoting NRF-1 transcription after its binding to the antioxidant response element (ARE) of the NRF-1 promoter (20 -22) .
NADPH-oxidase 4 (Nox4) is a constitutively active enzyme that predominantly produces H 2 O 2 (23) . Nox4-mediated oxidative stress has been involved in different cellular processes such as TGF-␤1-induced differentiation (24) , cytoskeletal dynamics (25, 26) , and transcriptional regulation (27, 28) . Nox4 has been localized to the mitochondria (29) where its interaction with complex I has been reported to inhibit the activity of this complex (30) . Additionally, Nox4 has been suggested to regulate urine levels of the metabolite fumarate by controlling the activity of fumarate hydratase (31) ; however, to date a knowledge gap remains regarding the role of Nox4 in controlling mitochondrial bioenergetics and metabolism.
Recent studies from our laboratory demonstrated that a redox imbalance underlies the persistence of lung fibrosis in response to airway injury in aged mice (32) . An increase in Nox4 activity associated with deficient Nrf2-driven cytoprotective responses characterizes this redox imbalance. Nrf2 is an oxidative stress-sensitive transcription factor that controls the expression of genes involved in antioxidant defense and detoxification (33) . Recent studies have suggested a fundamental role of Nrf2 in regulating mitochondrial function (34) .
In this study we investigated the role of Nox4 in mitochondrial biogenesis and bioenergetics. We found that endogenously expressed Nox4 represses mitochondrial biogenesis. This effect of Nox4 is mediated downstream of PGC-1␣ via a mechanism that involves Nrf2. This study supports the essential and opposing roles of Nox4 and Nrf2 signaling in the control of mitochondrial biogenesis and bioenergetics.
Results

Constitutive Nox4 Expression/Activity Regulates Mitochondrial Bioenergetics-
To determine whether Nox4 modulates mitochondrial bioenergetics, we analyzed oxygen consumption rate (OCR) of lung fibroblasts isolated from Nox4 ϩ/ϩ or Nox4 Ϫ/Ϫ mice. Nox4 Ϫ/Ϫ lung fibroblasts demonstrated a marked increase in maximal respiration in response to carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) compared with controls (Nox4 ϩ/ϩ fibroblasts). The reserve capacity, which represents the bioenergetic capacity of cells in response to increased energy demands or oxidative stress, was also significantly increased in Nox4 Ϫ/Ϫ lung fibroblasts compared with controls ( Fig. 1, A and B) . To investigate whether Nox4 deficiency mediates its effect on OCR by up-regulating the electron transport chain (ETC) activity, we measured the oxidation of complex I and II linked substrates. In this assay Nox4 ϩ/ϩ or Nox4 Ϫ/Ϫ lung fibroblasts were permeabilized with plasma membrane permeabilizer (PMP, a mutant recombinant perfringolysin O) (35) , and OCR was measured in response to exogenous addition of complex I or II substrates (pyruvate/ malate or succinate) and inhibitors of the ETC (rotenone or antimycin A) in the presence of ADP (36) . Complex I and II activity was significantly increased in Nox4 Ϫ/Ϫ lung fibroblasts compared with controls ( Fig. 1C ). Together, these data suggest that Nox4 negatively regulates mitochondrial bioenergetics, including the capacity of mitochondria to respond to increased energetic demand.
To confirm these observations, we next investigated whether the increase in OCR observed in Nox4-deficient cells results from the stimulation of mitochondrial biogenesis. Normal human lung diploid fibroblasts (IMR-90) were transfected with non-targeting (NT) or Nox4-specific siRNA. Nox4 silencing was confirmed at the mRNA level by real-time PCR ( Fig. 2A) . The mitochondrial-to-nuclear DNA ratio was quantified by real-time PCR. Nox4-silenced fibroblasts demonstrated a 3-fold increase (n ϭ 18, p Ͻ 0.005) in mitochondrial DNA copy number compared with controls ( Fig. 2B ). We observed similar effects on the mitochondrial-to-nuclear DNA ratio when Nox4 activity was blocked using the Nox1/Nox4 inhibitor GKT137831 (37), albeit to a lesser extent; a 1.8-fold increase compared with controls, n ϭ 12, p Ͻ 0.005 ( Fig. 2C ).
Mitochondrial biogenesis requires the up-regulation of TFAM, a transcription factor that ensures mitochondrial DNA replication during biogenesis. To determine whether Nox4 silencing mediates its effects on mitochondrial biogenesis via TFAM, we studied the effects of dual silencing of both Nox4 and TFAM on the mitochondrial-to-nuclear DNA ratio. Human lung fibroblasts were transfected with NT, Nox4, TFAM, or Nox4 plus TFAM siRNA (equal amounts of siRNA were transfected in each experimental group). Mitochondrial-to-nuclear DNA ratios were assessed for each experimental group by real-time PCR. As previously observed, Nox4 silencing led to an increase in mitochondrial-to-nuclear DNA ratios; a 2-fold increase compared with controls, n ϭ 9, p Ͻ 0.005 ( Fig. 3A ). As expected, TFAM silencing decreased the mitochondrial-to-nuclear DNA ratio; additionally, dual silencing of Nox4 and TFAM failed to rescue the increase in the mitochondrial-to-nuclear DNA ratio observed in Nox4-silenced cells. The silencing effi- ciency of Nox4 and/or TFAM was confirmed at the mRNA level by real time-PCR for each experimental group ( Fig. 3 , B, C, and D). These data suggest that Nox4 silencing stimulates mitochondrial biogenesis via TFAM.
Next, we analyzed the protein expression of mitochondrial markers, TFAM, citrate synthase (38) , the voltage-dependent anion channel (VDAC) (39) , and the cytochrome c oxidase subunit IV (COX IV) (40) in whole cell lysates of lung fibroblasts treated with NT, Nox4, TFAM, and Nox4ϩTFAM siRNA. The protein levels of these mitochondrial markers were increased in Nox4 siRNA-treated cells compared with controls, an effect that was partially reversed by silencing of TFAM in Nox4-silenced cells (Fig. 3 , E and F). Together, these data indicate that Nox4 silencing increases levels of mitochondrial proteins in human lung fibroblasts via TFAM up-regulation.
TFAM Induction in Nox4-deficient Cells Is Independent of PGC-1␣ Activation-Mitochondrial biogenesis has been reported to be induced by the phosphorylation of PGC-1␣, a co-activator of transcription that binds to NRF-1 to activate the expression of genes involved in mitochondrial biogenesis (12, 14) . TFAM is a downstream target of PGC-1␣ (5). To determine whether Nox4 silencing mediates its effect on mitochondrial biogenesis by activating the PGC-1␣/NRF-1 axis for mitochondrial biogenesis signaling, we analyzed the expression of phosphorylated PGC-1␣ and TFAM in total cell lysates isolated from control or Nox4-silenced human lung fibroblasts. We observed that Nox4 silencing did not induce PGC-1␣ phosphorylation ( Fig. 4, A and B) , whereas it led to a 3-fold increase in TFAM protein levels compared with controls (n ϭ 3, p Ͻ 0.005) ( Fig. 4, A and C) . These data suggest that Nox4 silencing stimulates mitochondrial biogenesis by increasing TFAM protein levels independently of PGC-1␣ activation.
Up-regulation of TFAM in Nox4-silenced Cells Is Mediated by Nrf2 but Is Independent of NRF1 and c-Myc-To determine whether Nox4 silencing increases TFAM protein levels through promoting TFAM transcription, we analyzed TFAM transcript levels by real-time PCR in control or Nox4-silenced cells. Nox4 silencing efficiency was assessed by real-time PCR. Nox4 silencing resulted in a 96% reduction of Nox4 mRNA level (data not shown). We observed a significant increase in TFAM transcript levels in Nox4-silenced compared with control cells (Fig. 5A ). NRF-1, Nrf2, and c-Myc have been shown to activate TFAM transcription (20, (41) (42) (43) (44) . We analyzed the protein levels of these transcription factors in nuclear and cytosolic fractions isolated from control or Nox4-silenced cells. Although we did not observe any significant effect of Nox4 silencing on the levels of nuclear NRF-1 or c-Myc (n ϭ 4), we observed a 2-fold increase (n ϭ 4, p Ͻ 0.005) in nuclear Nrf2 levels in Nox4-deficient lung fibroblasts compared with controls ( Fig.  5 , B-E). These data suggest that Nox4 silencing might stimulate mitochondrial biogenesis by promoting TFAM transcription through an Nrf2-dependent mechanism in human lung fibroblasts.
To determine whether Nox4 silencing induces mitochondrial biogenesis via Nrf2 activation, we analyzed the effect of silencing Nox4, Nrf2, or both Nox4 and Nrf2 on the levels of mitochondrial proteins in human lung fibroblasts. We analyzed the protein levels of TFAM, citrate synthase, and COX IV in total cell lysates and mitochondrial fractions isolated from NT, Nox4, Nrf2, or Nox4ϩNrf2 siRNA-transfected lung fibroblasts (equal amounts of siRNA were transfected in each experimental group). Nox4 silencing increased the levels of TFAM, citrate synthase, and COX IV in both total cell lysates and mitochondrial fractions (Fig. 6 , A-C). The silencing of Nrf2 in Nox4deficient lung fibroblasts attenuated, in part, the increase in mitochondrial markers ( Fig. 6 , A-C). These data suggest that Nrf2 contributes to regulation of mitochondrial biogenesis induced by Nox4 deficiency.
In addition, similar to a previous study (45) , we found that Nrf2 silencing led to a decrease in Nox4 mRNA expression ( Fig. 6D) . A redox-dependent co-regulation of these proteins was further supported by the finding that Nox4 silencing increased the levels of Nrf2 mRNA (Fig. 6E) , which is consistent with the effect of Nox4 silencing in increasing nuclear Nrf2 protein (Fig. 5, B and D) . The analysis of Nrf2 protein levels in nuclear fractions isolated from NT, Nox4, Nrf2, or Nox4ϩNrf2 siRNA-transfected fibroblasts confirmed its FEBRUARY 17, 2017 • VOLUME 292 • NUMBER 7 JOURNAL OF BIOLOGICAL CHEMISTRY 3031 efficient silencing (Fig. 6F ). NRF-1 and c-Myc protein levels remained similar between controls and Nrf2-deficient cells (Fig. 6F) . Together, these data support the concept that derepression of Nrf2 by Nox4 silencing contributes to TFAM expression and mitochondrial biogenesis in human lung fibroblasts.
Nox4 and Nrf2 Control of Lung Fibroblast Bioenergetics
Constitutive Nox4 Expression Regulates Mitochondrial Bioenergetics via Nrf2-To confirm whether Nox4 modulates mitochondrial bioenergetics via a Nrf2-dependent mechanism, we investigated the effect of silencing Nox4 or Nox4ϩNrf2 on OCR in human lung fibroblasts. Nox4-silenced cells exhibited a significant increase in basal, ATP-linked, maximum, and reserve OCR compared with controls (NT siRNA-transfected cells) (Fig. 7, A and B) . This up-regulation of mitochondrial bioenergetics in Nox4-deficient cells was abrogated in Nox4 and Nrf2 double-deficient cells. Additionally, CI and CII activity was significantly enhanced in Nox4-deficient lung fibroblasts compared with controls ( Fig. 7C ). This effect of Nox4 silencing on CI and CII activity was also abrogated when Nrf2 was co-silenced. 
Of note, the maximum mitochondrial respiration and reserve capacity were significantly reduced in Nrf2-deficient cells compared with controls ( Fig. 7, A and B) . This effect of Nrf2 silencing on maximum mitochondrial respiration and reserve capacity was abrogated in Nox4 and Nrf2 dually silenced cells. These data indicate that repression of mitochondrial bioenergetics by endogenous Nox4 in lung fibroblast is mediated via inhibition of an Nrf2-dependent mechanism.
Discussion
The regulation of mitochondrial biogenesis and bioenergetics is a crucial adaptive response that allows organisms to survive stress or exercise (46) . Although a number of studies report changes in mitochondrial bioenergetics and/or biogenesis to specific stimuli, mechanisms of the control of constitutive mitochondrial bioenergetics are unknown.
Our study is the first to demonstrate that Nox4 regulates mitochondrial biogenesis and bioenergetics. Our study also shows that this effect of Nox4 on mitochondrial bioenergetics and biogenesis is partly mediated by the control of endogenous Nrf2 and TFAM expression ( Fig. 8) .
Our data suggest that Nox4 modulates the activity of enzymatic complexes within the ETC. Work of others has shown that Nox4 is localized to the mitochondria (29, 47) where its interaction with complex I inhibits the activity of this complex (30, 48) . Our data imply that, in addition to direct effects, Nox4 represses mitochondrial biogenesis, which indirectly alters bioenergetics and reserve capacity; this regulation of mitochondrial bioenergetics by Nox4 may be part of a quality-control mechanism by which lung fibroblasts preserve mitochondrial integrity at baseline by preventing function-associated damages (49 -51) .
Our data indicate that the regulation of mitochondrial biogenesis in human lung fibroblasts by Nox4, at baseline, is mediated via a mechanism independent of PGC-1␣. Mitochondrial biogenesis in response to specific stimuli is a PGC-1␣-driven process that predominantly induces TFAM expression through NRF-1 co-activation at the TFAM promoter site (13, 52) . Because PGC-1␣ is an integrator of multiple extracellular stimuli-associated signaling pathways (nutrient status, temperature, growth hormones) (53) , it is possible that PGC-1␣ does not participate in the regulation of mitochondrial homeostasis at baseline and may predominantly drive mitochondrial adaption in response to specific stimuli.
Our data show that Nox4 silencing increases Nrf2 levels in the nucleus of human lung fibroblasts. Because oxidative stress induces Nrf2 translocation to the nucleus (54 -57) , where it activates the transcription of genes involved in cytoprotective responses (58) , this unexpected finding suggests oxidant stress responses independent of Nox4 or that Nrf2 can be activated by a non-redox mechanism. In support of a Nox4-independent oxidative stress pathway, it has been shown that Nox4 downregulates the activity of complex I in the mitochondria (30) . Complex I of the ETC is one of the major sites of mitochondrial ROS production (50) . Therefore, the silencing of Nox4 may affect its interaction with complex I in the mitochondria and promote ROS formation at this complex. The precise mechanism(s) of how endogenous Nox4 represses Nrf2 require further study.
Our data suggest that endogenous Nox4 represses mitochondrial bioenergetics and biogenesis via decreasing Nrf2 induction and activation. This observation is consistent with reports that link Nrf2 activation to mitochondrial function (34) . Nrf2 has also been reported to regulate mitochondrial membrane potential, mitochondrial respiration, and ATP production (59) .
Fibroblasts are key in wound-healing processes (60) . During wound repair, fibroblasts reprogram their metabolism to meet the accrued energetic needs associated with their function. The knowledge of mechanisms governing mitochondrial functions in resting conditions may help our understanding of how fibroblasts are primed to respond to lung injury. 
Experimental Procedures
Animals-Nox4 knock-out mice were a gift from Karl-Heinz Krause, University of Geneva. Mice were sacrificed by CO 2 inhalation. All procedures involving animals were approved by the Institutional Animal Care and Use Committees (IACUC) at the University of Alabama at Birmingham.
Cell Culture-Lung fibroblasts were isolated from Nox4 ϩ/ϩ or Nox4 Ϫ/Ϫ mice. In brief, mouse lung tissue was collected and minced in ice-cold PBS. The minced tissue was then digested with collagenase (1 mg/ml, Worthington (Lakewood, NJ)) for 30 min at 37°C and filtered through a 100-m cell strainer. Collagenase was neutralized by adding 10% fetal calf serum-containing DMEM. After centrifugation (1000 rpm, 5 min), cells were plated in 100-mm dishes for culture. Primary mouse lung fibroblasts were passaged one time before experimentation.
Human fetal lung fibroblasts (IMR-90 cells) at low population doubling (PDL 7) were purchased from Coriell Cell Repositories (Camden, NJ). All cells (primary cultures and IMR-90) were cultured in DMEM (Life Technologies) supplemented with 10% fetal calf serum (HyClone Laboratories, Logan, UT), 100 units/ml penicillin, 100 g/ml streptomycin, 1.25 g/ml amphotericin B, and 2 mM L-glutamine at 37°C in 5% CO 2 , 95% air.
Reagents-GKT137831 was a generous gift from Genkyotex (Geneva, Switzerland). Plasma membrane permeabilizer (PMP, a mutant recombinant perfringolysin O) was purchased from Seahorse Bioscience. Protease and phosphatase inhibitor mixtures (complete, Mini, EDTA-free, and PhosSTOP) were purchased from Roche Applied Science. We purchased antibodies (Ab) to ␤-actin (clone AC-15, mouse monoclonal Ab against N-terminal peptide, catalogue #A1978, lot #043M4840V) and ␣-tubulin (clone B-5-1-2, mouse mAb against C-terminal peptide, catalogue #T5168, lot #103M4773V) from Sigma; TFAM (clone D5C8 rabbit mAb against peptide containing Val-225, catalogue #8076S, lot #1), total PGC-1␣ (rabbit mAb against PGC-1␣ fusion protein, catalogue #2178S, lot #2), c-Myc (clone D3N8F, rabbit mAb against central region of human c-Myc, catalogue #12987S, lot #1), NRF-1 (rabbit Ab against peptide near Leu167, catalogue #12381, lot #1), VDAC (clone D73D12, rabbit mAb against N-terminal peptide, catalogue #4661S, lot #5), citrate synthase (clone D7V8B, rabbit mAb against residues near the C terminus of the protein, catalogue #14309S, lot #1) and COX IV (clone 3E11, rabbit mAb against synthetic peptide corresponding to residues surrounding Lys29 of human COX IV, catalogue #4850S, lot #6) from Cell Signaling Technology (Boston, MA); lamin A/C (clone 636, mouse mAb against lamin preparation of porcine origin, catalogue #sc-7292, lot #F3011) was purchased from Santa Cruz Biotechnology (Dallas, TX); Nrf2 (rabbit Ab against fusion protein from amino acids 256 -605, catalogue #16396-1-AP, lot #00043173) was from Proteintech Group Inc. (Rosemont, IL); phospho-PGC-1␣ rabbit Ab against Ser-571, catalogue #AF6650, lot #CEBA0114011) was from R&D Systems (Minneapolis, MN).
Assessment of Bioenergetics and Mitochondrial
Assay-Primary mouse lung fibroblasts were plated on Seahorse Extracellular Analyzer XF96 plates in serum-free culture media. Measurements of the OCR and the activity of complex I and II of the ETC were measured as described in Refs. 36, 61, and 62). FEBRUARY 17, 2017 • VOLUME 292 • NUMBER 7
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RNA Interference-siRNA targeting Nox4, TFAM, and Nrf2 as well as non-targeting controls were purchased from Invitrogen TM (Stealth siRNA technology; for siRNA sequences, see Table 1 ). siRNA were transfected into lung fibroblasts using Lipofectamine RNAiMAX (Invitrogen TM ) at a final concentration of 100 nM. 48 h post transfection, lung fibroblasts were growth-arrested by replacing the transfection media with serum-free DMEM supplemented with 2 mM L-glutamine.
Western Immunoblotting-Total cell lysates were prepared using radioimmune precipitation assay buffer (150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0; Sigma) supplemented with protease and phosphatase inhibitors. Cytosolic and nuclear fractions were isolated using the NE-PER Nuclear and Cytosolic Extraction kit (Thermo Scientific). Mitochondrial fractions were isolated using the Mitochondria Isolation Kit for Cultured Cells (Thermo Scientific). The total protein concentration of lysates or cell fractions was quantitated using a Micro BCA Protein Assay kit (Thermo Scientific) or the DC Protein Assay kit (Bio-Rad). Lysates were then subjected to SDS-PAGE under reducing conditions, and Western immunoblotting was performed as described previously (3) . Immunoblots were imaged using an Amersham Biosciences 600 Imager (GE Healthcare). Signals were quantitated using ImageQuant TL software.
Real-time PCR-Real-time PCR was performed as described in Ref. 62 . Primer sequences for Nox4, TFAM, and Nrf2 are given in Table 2 .
Quantification of the Mitochondrial-to-nuclear DNA Ratio-The ratio of mitochondrial to nuclear DNA was assessed by real-time PCR using the Human Mitochondrial DNA Monitoring Primer Set Ratio kit (Takara Bio, Mountain View, CA). 
